Top News

Cardium Gets Strategic Funding From China

San Diego-based Cardium Therapeutics said Monday that it has scored a strategic funding from Shanxi Taxus Pharmaceuticals Co., Ltd., to help support development of its regenerative medicine therapeutics products. According to Cardium, the deal is worth up to $5.0M to support commercialization of its products. The publicly traded company said it will change its name to Taxus Cardium Pharmaceuticals Group in connection with the deal. More information »


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel